Former OpenAI executive founded a company with robots for drug discovery

Description and use

<p>Former OpenAI science lead Kevin Weil has launched Warp Sciences, an AI startup focused on automating laboratory work for drug discovery.</p> <p>The company uses robots to synthesize and test compounds, backed by $215 million in funding led by Lightspeed.</p> <p>The company trains robots to build and test promising chemical compounds that researchers identify. Through this automation, Warp Sciences hopes to speed up the drug development process by using robots that can operate non-stop around the clock.</p> <h2> Financing and investors </h2> <p>According to Weil, the startup has raised $215

Problem

<p>Former OpenAI science lead Kevin Weil has launched Warp Sciences, an AI startup focused on automating laboratory work for drug discovery.</p> <p>The company uses robots to synthesize and test compounds, backed by $215 million in funding led by Lightspeed.</p> <p>The company trains robots to build and test promising chemical compounds that researchers identify. Through this automation, Warp Sciences hopes to speed up the drug development process by using robots that can operate non-stop around the clock.</p> <h2> Financing and investors </h2> <p>According to Weil, the startup has raised $215

Outcome

<p>Former OpenAI science lead Kevin Weil has launched Warp Sciences, an AI startup focused on automating laboratory work for drug discovery.</p> <p>The company uses robots to synthesize and test compounds, backed by $215 million in funding led by Lightspeed.</p> <p>The company trains robots to build and test promising chemical compounds that researchers identify. Through this automation, Warp Sciences hopes to speed up the drug development process by using robots that can operate non-stop around the clock.</p> <h2> Financing and investors </h2> <p>According to Weil, the startup has raised $215

Evidence

Former OpenAI executive founded a company with robots for drug discovery

Source